Cote d'Ivoire vs South Africa: Access to anti-retroviral drugs, female
Cote d'Ivoire
84.0%
in 2024
South Africa
84.0%
in 2024
Cote d'Ivoire rank
50th
South Africa rank
50th
Access to anti-retroviral drugs, female over time
- Cote d'Ivoire
- South Africa
How they compare
Cote d'Ivoire currently reports 84.0% against 84.0% in South Africa, a difference of 0.0%.
Across all 25 years both countries report, South Africa has been ahead every year.
Cote d'Ivoire ranks 50th and South Africa ranks 50th of 141 countries.
South Africa has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.8% | 6.1% | 1.3% | South Africa |
| 2010s | 41.6% | 54.6% | 13.0% | South Africa |
| 2020s | 78.2% | 81.8% | 3.6% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Cote d'Ivoire or South Africa?
- Cote d'Ivoire, at 84.0% against 84.0% in South Africa as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Cote d'Ivoire and South Africa?
- 0.0%, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Cote d'Ivoire and South Africa?
- 25 years are reported by both, from 2000 to 2024.
- How do Cote d'Ivoire and South Africa rank globally for access to anti-retroviral drugs, female?
- Cote d'Ivoire ranks 50th and South Africa ranks 50th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.